Pre-sterilized biomanufacturing represents a modern shift in the biotech industry, advancing away from traditional platforms. Such strategy incorporates pre-sterilized vessels and components, lowering cleanup times, decreasing plant footprint, and potentially speeding drug production. Furthermore, it can decrease total costs and boosts versatility